Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Gliosarcoma 3Glioma 3Glioblastoma 3Dendritic Cell Sarcoma, Interdigitating 3Oligodendroglioma 2Astrocytoma 2Sarcoma, Kaposi 1Recurrence 1Neuroectodermal Tumors, Primitive 1Meningioma 1Lymphoma 1Histiocytosis, Langerhans-Cell 1Histiocytic Sarcoma 1Heart Failure 1HIV Infections 1Erdheim-Chester Disease 1Ependymoma 1Central Nervous System Neoplasms 1Cardiotoxicity 1Brain Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

Magnetic Resonance Spectroscopy 15Temozolomide 14Radiotherapy 6Filgrastim 6Carmustine 6Biopsy 6X-Rays 5Phantoms, Imaging 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5sargramostim 4Specimen Handling 4Peripheral Blood Stem Cell Transplantation 4Nuclear Medicine Department, Hospital 4Cyclophosphamide 4Thiotepa 3Gadolinium DTPA 3Cisplatin 3Carboplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2fluorodopa F 18 2ensartinib 2aldesleukin 2Yoga 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × Lenalidomide × Sarcoma × Clear all
NCT00036894 2015-04-30

CC-5013 in Treating Patients With Recurrent Glioma

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡